US Dollar vs Yen

登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

登録

ホーム
投資
株式
アメリカ
NYSE
Zymeworks Inc (ZYME)
Zymeworks Inc (ZYME) ニュース

ZYME

Zymeworks (ZYME)

Zymeworks Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NYSE:ZYME

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2023/06/30	05 : 12	Edgar (US Regulatory)	Current Report Filing (8-k)	NYSE:ZYME	Zymeworks Inc
2023/06/22	05 : 05	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:ZYME	Zymeworks Inc
2023/06/13	05 : 26	Edgar (US Regulatory)	Amended Securities Registration (section 12(b)) (8-a12b/a)	NYSE:ZYME	Zymeworks Inc
2023/06/13	05 : 07	Edgar (US Regulatory)	Current Report Filing (8-k)	NYSE:ZYME	Zymeworks Inc
2023/06/05	19 : 03	Edgar (US Regulatory)	Current Report Filing (8-k)	NYSE:ZYME	Zymeworks Inc
2023/06/03	08 : 23	PR Newswire (US)	Jazz Pharmaceuticals and Zymeworks Present Positive Pivotal Phase 2b Trial Data at ASCO 2023 Evaluating Zanidatamab in HER2-Amplified Biliary Tract Cancers	NYSE:ZYME	Zymeworks Inc
2023/05/18	21 : 41	Edgar (US Regulatory)	Current Report Filing (8-k)	NYSE:ZYME	Zymeworks Inc
2023/05/16	21 : 31	Edgar (US Regulatory)	Current Report Filing (8-k)	NYSE:ZYME	Zymeworks Inc
2023/05/09	06 : 20	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NYSE:ZYME	Zymeworks Inc
2023/05/09	05 : 14	Edgar (US Regulatory)	Current Report Filing (8-k)	NYSE:ZYME	Zymeworks Inc
2023/04/29	05 : 18	Edgar (US Regulatory)	Amended Annual Report (10-k/a)	NYSE:ZYME	Zymeworks Inc
2023/04/26	21 : 31	Edgar (US Regulatory)	Current Report Filing (8-k)	NYSE:ZYME	Zymeworks Inc
2023/04/11	05 : 46	Edgar (US Regulatory)	Current Report Filing (8-k)	NYSE:ZYME	Zymeworks Inc
2023/03/16	05 : 17	Edgar (US Regulatory)	Current Report Filing (8-k)	NYSE:ZYME	Zymeworks Inc
2023/03/15	06 : 01	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:ZYME	Zymeworks Inc
2023/03/08	07 : 25	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NYSE:ZYME	Zymeworks Inc
2023/03/08	06 : 09	Edgar (US Regulatory)	Current Report Filing (8-k)	NYSE:ZYME	Zymeworks Inc
2023/02/15	06 : 47	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NYSE:ZYME	Zymeworks Inc
2023/02/15	06 : 02	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NYSE:ZYME	Zymeworks Inc
2023/02/15	04 : 38	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NYSE:ZYME	Zymeworks Inc
2023/02/11	07 : 29	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NYSE:ZYME	Zymeworks Inc
2023/01/25	22 : 30	Business Wire	Zymeworks Announces Participation in Upcoming Investor Conferences	NYSE:ZYME	Zymeworks Inc
2023/01/24	08 : 01	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:ZYME	Zymeworks Inc
2023/01/19	22 : 11	Edgar (US Regulatory)	Current Report Filing (8-k)	NYSE:ZYME	Zymeworks Inc
2023/01/19	21 : 45	PR Newswire (US)	Jazz Pharmaceuticals and Zymeworks Announce 84% Overall Survival at 18 Months from Phase 2 Trial Evaluating Zanidatamab in HER2-Expressing Metastatic Gastroesophageal Adenocarcinoma	NYSE:ZYME	Zymeworks Inc
2023/01/19	21 : 45	PR Newswire (US)	Jazz Pharmaceuticals and Zymeworks Announce 84% Overall Survival at 18 Months from Phase 2 Trial Evaluating Zanidatamab in HER2-Expressing Metastatic Gastroesophageal Adenocarcinoma	NYSE:ZYME	Zymeworks Inc
2023/01/13	06 : 48	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:ZYME	Zymeworks Inc
2023/01/05	06 : 22	Edgar (US Regulatory)	Current Report Filing (8-k)	NYSE:ZYME	Zymeworks Inc
2023/01/05	06 : 15	Business Wire	Zymeworks Provides Corporate Update on Key Strategic Priorities and Outlook for 2023	NYSE:ZYME	Zymeworks Inc
2023/01/04	07 : 02	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NYSE:ZYME	Zymeworks Inc

Showing the most relevant articles for your search:NYSE:ZYME

1 2 3 4 5 6 7 8 9 10 次へ >>

NLBNPIT1UIB0 20991231 6....

Republic of Finland

Rl Fin Bds Perp

Caisse Depots Et Consign...

Melco Resorts & Entertai...

iShares S&P 500 GBP Hedg...

FTSE 350 Software and Co...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約